Barry Honig is one of the biotech space’s most renowned entrepreneurs and investors. Along with his compatriot, Dr. Phillip Frost, he has been responsible for some of the big name successes in the sector. Many investors like to piggyback his positions, so here’s one he just announced.
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bioptix Inc. (NASDAQ:BIOP) reported that Honig Barry C. has picked up 504,000 of common stock as of 2017-01-05.
The acquisition brings the aggregate amount owned by Honig Barry C. to a total of 504,000 representing a 11.19% stake in the company.
For those not familiar with the company, Bioptix, Inc., formerly Venaxis, Inc., provides Enhanced Surface Plasmon Resonance (SPR) platform for the detection of molecular interactions. The Company’s line of Enhanced SPR instruments are designed to increase the flexibility and reliability of SPR. Its SPR biosensors shed light on important binding parameters that are crucial for determining whether a biologic or small molecule drug will be efficacious in humans and at what dose a drug should be administered. Its technology is an ultra-sensitive detection platform. The design of its SPR spectrometers allows discrete areas within the sample cell to be interrogated simultaneously by use of photo-diode arrays aligned to the reflected beam from the sample cell.
A glance at Bioptix Inc. (NASDAQ:BIOP)’s key stats reveals a current market capitalization of 21.28 million based on 4.50 million shares outstanding and a price at last close of $4.12 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-01-04, Honig picked up 4,000 at a purchase price of $4.22. This brings their total holding to 443,585 as of the date of the filing.
On the sell side, the most recent transaction saw Hepler unload 17,700 shares at a sale price of $2.17. This brings their total holding to 41,300.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Bioptix Inc. (NASDAQ:BIOP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
